
Jeffrey Cranmer
Executive Editor at BioCentury
Co-Host at BioCentury This Week
Executive Editor, @BioCentury. Jersey boy happily ensconced in Cali. Dad. Failed poet. Devoted Iggles fan. Cats. @Princeton, @SAISHopkins alum. Opinions? Mine.
Articles
-
Mar 5, 2020 |
biocentury.com | Jeffrey Cranmer
-
Feb 14, 2019 |
biocentury.com | Jeffrey Cranmer
-
Sep 16, 2018 |
biocentury.com | Jeffrey Cranmer
-
Sep 12, 2018 |
biocentury.com | Jeffrey Cranmer
-
Sep 6, 2018 |
biocentury.com | Jeffrey Cranmer
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 2K
- Tweets
- 5K
- DMs Open
- Yes

Small molecule #Alzheimer's tx hits Ph 3 setback at #ADPD2025, but study's PIs argue for a subgroup effect in early-stage patients and a new surrogate endpoint -- hippocampal volume. My @BioCentury colleague @SelinaMKoch reports on the data as presented in Vienna at @adpdnet

"Not exactly a pick-me-up" says my @BioCentury pal @BioPharmaJosh about the new #BioCenturyThisWeek biotech podcast! But trust him, it's the stuff you need to know about what's happening to @US_FDA & $XBI. w/@steveusdin1 @FishburnSimone @StephenPHansen https://t.co/kApqNAoe54

RT @ScottGottliebMD: 🧵 Twenty-five years ago, it was common to hear complaints about a “drug lag”—the perception that Europeans routinely e…